Graypoint LLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.

Quarter-by-quarter ownership
Graypoint LLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$1,194,024
-11.6%
43,995
+0.1%
0.11%
-16.4%
Q2 2023$1,350,992
-14.7%
43,9490.0%0.13%
-22.1%
Q1 2023$1,583,482
-8.9%
43,949
-0.1%
0.17%
-16.9%
Q4 2022$1,737,892
-48.5%
43,975
-47.6%
0.21%
-52.3%
Q3 2022$3,375,000
-4.4%
84,0010.0%0.43%
-4.2%
Q2 2022$3,531,000
-84.0%
84,001
-85.2%
0.45%
-79.2%
Q1 2022$22,039,000
-2.2%
565,674
+0.0%
2.18%
-7.8%
Q4 2021$22,539,000
+2.1%
565,584
-7.4%
2.36%
-12.8%
Q3 2021$22,067,000
+199.2%
610,584
+239.4%
2.71%
+176.6%
Q2 2021$7,375,000179,9160.98%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 2,680,644$106,824,00067.12%
SIGULER GUFF ADVISERS, LLC 6,761,970$269,465,00056.37%
Vantage Consulting Group Inc 4,601,152$183,355,00049.30%
Indie Asset Partners, LLC 805,982$32,118,00023.31%
HARVARD MANAGEMENT CO INC 3,464,990$138,080,00012.96%
Brown University 621,759$24,777,0006.04%
Overbrook Management Corp 729,125$29,056,0005.86%
Bleichroeder LP 824,033$32,838,0005.13%
Geo Capital Gestora de Recursos Ltd 200,692$7,998,0003.81%
Lagoda Investment Management, L.P. 140,435$5,596,0002.65%
View complete list of ROYALTY PHARMA PLC shareholders